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Abstract Here in , we inves t iga ted whe the r
subdiaphragmatic vagotomy has benefits on obesity,
body glucose homeostasis, and insulin secretion in caf-
eteria (CAF)-obese rats. Wistar rats were fed a standard
or CAF diet for 12 weeks. Subsequently, CAF rats were
randomly submitted to truncal vagotomy (CAF Vag) or
sham operation (CAF Sham). CAF Sham rats were
hyperphagic, obese, and presented metabolic distur-
bances, including hyperinsulinemia, glucose intoler-
ance, insulin resistance, hyperglycemia, and hypertri-
glyceridemia. Twelve weeks after vagotomy, CAF Vag
rats presented reductions in body weight and
perigonadal fat stores. Vagotomy did not modify glu-
cose tolerance but normalized fed glycemia,
insulinemia, and insulin sensitivity. Isolated islets from
CAF Sham rats secreted more insulin in response to the
cholinergic agent, carbachol, and when intracellular cy-
clic adenine monophosphate (cAMP) is enhanced by
forskolin or 3-isobutyl-1-methylxanthine. Vagotomy
decreased glucose-induced insulin release due to a re-
duction in the cholinergic action on β-cells. This effect
also normalized islet secretion in response to cAMP.
Therefore, vagotomy in rats fed on a CAF-style diet
effectively decreases adiposity and restores insulin sen-
sitivity. These effects were mainly associated with the
lack of cholinergic action on the endocrine pancreas,
which decreases insulinemia and may gradually reduce
fat storage and improve insulin sensitivity.
Keywords Truncal vagotomy. Cafeteria diet . Glucose
homeostasis . Insulin secretion . Obesity
Introduction
Obesity is rapidly expanding worldwide and predis-
poses to several diseases, including hypertension, car-
diovascular diseases, cancer, and type 2 diabetes (T2D)
[16]. Although several factors may contribute to the
development of the obesity [32], evidence suggests that
an autonomic nervous system (ANS) dysfunction con-
tributes to increased adiposity and maintain this syn-
drome [8, 9, 31].
The ANS regulates several aspects of energy homeo-
stasis through both parasympathetic and sympathetic
branches [21]. The parasympathetic nervous system
(PNS) transmits peripheral signals to the central nervous
system (CNS), regulating food intake, through the af-
ferent fibers in the vagus nerves [25]. Efferent vagal
fibers, which comprise less than 20% of the vagus nerve
fibers, indirectly control energy homeostasis by
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regulating gastric emptying and accommodation, hepat-
ic glucose and lipid metabolism, and insulin secretion
[15, 18, 21, 22].
Hyperinsulinemia is a common finding in the early
stages of obesity development [13, 26]. Pancreatic islets
are richly innervated by the PNS and SNS, which in-
crease and decrease, respectively, insulin secretion [1].
Since truncal vagotomy in morbid obese patients [17],
and in hypothalamic [3] and genetic obese rodents [26],
normalized insulin plasma levels, it has been suggested
that, in obesity, an unbalance in ANS action, with in-
crease in PNS activity, but reduction in SNS action,
contributes to the etiology of this syndrome [27, 29].
Several experimental rodent models are used in basic
research to understand the pathophysiology of obesity.
Among these, the model that most accurately resembles
the intake of the highly palatability foods that are prev-
alent in the Western society and represents the actual
human obesogenic condition is the cafeteria (CAF) diet
[28]. The consumption of a CAF diet in rodents pro-
motes obesity, hyperinsulinemia, glucose intolerance,
and insulin resistance [2, 28, 34]. Despite the involve-
ment of ANS dysfunction, more specifically PNS hy-
peractivity, in the development of hypothalamic, genetic
and high-fat diet obesity has been often investigated [3,
19, 26, 31]; no studies have reported the contribution of
the PNS on CAF diet obesity. Therefore, we herein
investigate the effects of subdiaphragmatic vagotomy
on obesity, body glucose homeostasis, and insulin se-
cretion in CAF-obese rats.
Materials and methods
Experimental groups
All experiments were approved by the University’s
Committee for Ethics in Animal Experimentation
(CEEAAP/UNIOESTE no. 8709). Eight-week-old male
Wistar rats were randomly divided into two groups:
control (CTL, n = 10), which received standard rodent
chow (Biobase®, Águas Frias, SC, BRA) consisting of
3.8 kcal/g (70 % carbohydrate, 20 % protein and 10 %
fat) and filtered water ad libitum, or the Cafeteria (CAF,
n = 16) group, which received a cafeteria diet. Table 1
presents the nutritional composition of foods offered to
the animals in the standard chow and cafeteria diet.
After 12 weeks of CAF diet consumption, CAF
rats were submitted to subdiaphragmatic truncal
vagotomy (CAF Vag group, n = 08) or a sham
operation (CAF Sham, n = 08). For this procedure,
12-h fasted rats were anesthetized with a mixture
of ketamine and xylazine (90 and 9 mg/kg via i.p.,
respectively; Vetbrands®, Paulínia, SP, BRA). Sub-
sequently, the stomach and esophagus were exteri-
orized from the peritoneal cavity, and both dorsal
and subdiafragmatic vagal trunk was separated
from the esophagus and cut off. Sham-operation
rats underwent the same procedures, but the vagus
nerve was kept intact. At the end of the experi-
mental period, to confirm subdiaphragmatic vagot-
omy, stomach food retention from all groups of
rats was evaluated by the ratio between the stom-
ach weight per body weight (BW) [3].
ipGTT
After 12 weeks of subdiaphragmatic vagal denerva-
tion, rats were submitted to 8 h fasting and a blood
sample was taken from the tail tip to obtain fasting
glucose (time 0), using a glucose analyzer (Abbott®,
Optium Xceed, Alameda, CA). Subsequently, all
groups of rats received an i.p. injection of 2 g/kg
BW glucose, and blood glucose was also analyzed
Table 1 Nutritional composition of the diets given to the rats
Cafeteria diet composition (%)
Cheetos Balls snack (Cheetos, Pepsico, Brazil) 11
Bacon snack (Troféu, Santa Helena, Brazil) 13
Cookie cornstarch (Zadimel, Brazil) 10
Chocolate cake (Renata, Selmi, Brazil) 10
Coca-Cola (Coca-Cola, Brazil) 1
Guaraná (Antarctica, AmBev, Brazil) 1
Italian salami (Sadia, Brazil) 11
Mixed sausage (Sadia, Brazil) 9
Nutrella bread (Nutrella, Brazil) 8
Chocolate wafer (Bauducco, Brazil) 13
Mortadella (Frimesa, Brazil) 5
Marshmallow (Fini, Brazil) 8
Macronutrients contents (%)
Standard diet Cafeteria diet
Carbohydrate 70 49
Lipids 10 24
Proteins 20 22
kcal/g 3.8 5.4
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after 15, 30, 60, 120, and 180 min of glucose ad-
ministration. Additional blood samples were collect-
ed at 0 and 30 min of the test to measure insulin by
radioimmunoassay (RIA).
Obesity and general nutritional parameters
Body weight was measured weekly for 23 weeks.
During the last week, four rats per group were
maintained in individual metabolic cages for 5 days,
for measurement of 12 h food and fluid intake, and
amount of urine and feces excreted. After 12 weeks
of subdiaphragmatic vagotomy, the final BW and
nasoanal length were measured to calculate the Lee
index [ratio of BW (g)/nasoanal length (cm) × 1000]
[5]. Subsequently, all groups of rats were euthanized
by decapitation, and total blood samples were col-
lected to measure glucose (as above mentioned),
insulin by RIA, total cholesterol (CHOL), and tri-
glycerides (TG) using standard commercial kits
® ®
were also removed and weighed.
HOMA-IR
Tissue insulin sensitivity was evaluated by the previous-
ly validated [6] homeostasis model of assessment
(HOMA) using the HOMA index of insulin resistance
[(HOMA-IR) = fasting insulin (μU/mL) × fasting glu-
cose (mM)/22.5] [23].
Pancreatic islet isolation and static insulin secretion
Islets were isolated by collagenase (Sigma-Aldrich
Chemicals, St Louis, MO, USA) digestion of the
exocrine pancreas. For static incubations, four islets
from each group were incubated for 30 min at
37 °C, with 0.5-mL Krebs–bicarbonate (KBR) buff-
er with the following composition: 115 mM NaCl,
5 mM KCl, 2.56 mM CaCl2, 1 mM MgCl2, 10 mM
NaHCO3, 15 mM HEPES, supplemented with
5.6 mM glucose, 3 g BSA/L, pH 7.4, and aired
with a mixture of 95 % O2/5 % CO2. This medium
was discarded and the islets were incubated for a
further 1 h with 1-mL fresh KBR buffer containing
11.1 mM glucose without or with 100 μM carba-
chol (Cch), 10 μM forskolin, or 1 mM 3-isobutyl-
1-methylxanthine (IBMX). Aliquots of the superna-
tant were collected at the end of the incubation
period and kept at −20 °C for posterior insulin
measurement by RIA.
Statistical analysis
Results are presented as means ± SEM for the number of
determinations (n) indicated. Statistical analyses were
carried out using one-way analysis of variance
(ANOVA) followed by the Tukey posttest (P < 0.05).
Tests were performed using GraphPad Prism® version
5.00 for Windows (San Diego, CA, USA).
Results
General nutritional and obesity features
Body weight was measured weekly in the CAF and
CTL groups, as illustrated in Fig. 1a. CAF diet rats
were significantly heavier from the fourth week
after beginning the diet treatment, when compared
to CTL rats (P < 0.05; Fig. 1a). The total BW gain,
as judged by the area under the growth curve
(AUC), before the subdiaphragmatic vagotomy,
was higher in the CAF groups, when compared
with CTL rats (P < 0.01; Fig. 1b). After 2 weeks
of vagotomy, the BW in CAF Vag rats was lower
than that observed for CAF Sham rats (P < 0.03),
but similar to that of the CTL group (Fig. 1a). The
AUC of total BW gain during 11 weeks after vagal
denervation in CAF Vag group was also similar to
that registered for CTL rats (Fig. 1b and Table 2).
In addition, CAF Sham rats presented a higher final
BW and adiposity, as demonstrated by the 48 and
53 % increases in retroperitoneal and perigonadal
fat stores, respectively, and by the greater Lee in-
dex, when compared with the CTL group (P <
0.001, P < 0.03, and P < 0.001, respectively; Table
2). CAF Sham rats were also hyperphagic, consum-
ing 32 % more food in 12 h, in comparison with
CTL rats (P < 0.05; Table 2). The CAF-style diet
decreased feces produced in 12 h, enhancing the
ratio between the food consumed per residue ex-
creted (P < 0.0001 and P < 0.001; Table 2). After
12 weeks of subdiaphragmatic vagotomy, CAF
Vag rats presented reductions of 9 % in the Lee
index and 19 % in perigonadal fat pad weight,
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(Merck , Germany and Boehringer Mannhein, Ger-
many). Retroperitoneal and perigonadal fat pads
when compared with CAF Sham rats (P < 0.0001
and P < 0.05). Although the CAF Vag group pre-
sented only a partial reduction in food consump-
tion, without alteration in total feces excreted in
12 h, a significant lower ratio between food intake
per feces produced was observed in the CAF Vag
compared with the CAF Sham group (P < 0.05;
Table 2). Furthermore, the CAF Vag rats presented
a higher stomach weight per BW ratio, when com-
pared to the CAF Sham rats (P < 0.001; Table 2),
which confirmed the bilateral subdiaphragmatic
vagotomy. Fluid intake and urine excretion in
12 h were similar in all groups of rats (Table 2).
Glucose Homeostasis
The CAF-style diet increased glycemia and insulinemia
in both fasting and fed conditions in CAF Sham, when
compared with CTL rats (P < 0.0001 and P < 0.005;
F ig . 2a , b ) . A l though , a f t e r 12 weeks o f
subdiaphragmatic vagotomy, fasted CAF Vag rats also
displayed higher blood glucose (P < 0.05; Fig. 2a), this
glycemia was associated with a normal insulinemia
(Fig. 2b). In addition, normalizations of the glucose
and insulin plasma concentrations under fed conditions
were observed in the CAF Vag rats (Fig. 2a, b). The
CAF Sham rats also presented insulin resistance, since
HOMA-IR was 5.6- and 2.8-fold higher in the fasted
and fed conditions, respectively, than observed in CTL
rats (P < 0.001 and P < 0.05; Fig. 2c). Vagotomy nor-
malized insulin sensitivity in CAF Vag rats in both
conditions, when compared with CAF Sham rats (P <
0.05; Fig. 2c).
To analyze body glucose control, an intraperito-
neal glucose tolerance test (ipGTT) was performed
at 12 weeks after vagotomy and sham operations.
After glucose administration, glycemia reached
maximum levels at 15 min in all groups of rats
(Fig. 2d). CAF Sham rats presented persistent hy-
perglycemia from 30 to 120 min of the test, when
compared with CTL rats (P < 0.05; Fig. 2d). The
total glycemia during the ipGTT was 36 % higher
in the CAF Sham compared with CTL rats (P <
0.005; Fig. 2e). This effect was accompanied by a
higher insulin secretion in response to glucose ad-
ministration, since at 30 min of the test, insulinemia
was 86 % higher in CAF Sham rats in comparison
with the CTL group (P < 0.004; Fig. 2f). CAF Vag
rats also presented higher blood glucose at 30 and
120 min of the test (P < 0.01 and P < 0.05; Fig. 2f),
but total glycemia during ipGTT presented interme-
diary values compared to those of the CAF Sham
and CTL rats (Fig. 2e). In contrast, the CAF Vag rats
presented normal insulinemia at 30 min of the
ipGTT (Fig. 2f).
F u r t h e r m o r e , C A F S h a m r a t s w e r e
hypertriglyceridemic under fasting (188 ± 24 mg/
dL) and fed conditions (244 ± 32 mg/dL), when
compared with CTL (97 ± 9 and 117 ± 6 mg/dL,
respectively; P < 0.001). After 12 weeks of
Fig. 1 a Body weight of CTL, CAF Sham, and CAF Vag rats
recorded over 23 weeks. b Total BW before and after
subdiaphragmatic vagotomy, expressed by the area under curve
(AUC). *Indicates a significant statistical difference between CAF
Sham and CAF Vag groups from CTL. #CAF Sham is different
from CAF Vag and CTL. Different letters over the bars represent
significant differences. Data are means ± SEM (n = 6–10). One-
way ANOVA followed by the Tukey posttest, P < 0.05
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vagotomy, CAF Vag presented plasma TG concen-
trations (108 ± 14 and 117 ± 15 mg/dL, for fasting
and fed conditions, respectively) that were similar to
those of CTL rats. No alterations in total CHOL
Table 2 General features of CTL, CAF Sham, and CAF Vag rats
CTL CAF Sham CAF Vag
Food intake in 12 h (g) 19 ± 0.7a 25 ± 1b 22 ± 2ab
Feces excreted in 12 h (g) 4.0 ± 0.5a 0.8 ± 0.7b 1.3 ± 0.06b
Food intake/excreted feces ratio 4.9 ± 0.5a 32 ± 4.5b 9.3 ± 1.1c
Hydrous intake in 12 h (mL) 13 ± 1.7 9.5 ± 0.5 14 ± 2.2
Urine excreted in 12 h (mL) 12 ± 1.7 9.5 ± 0.6 9.3 ± 1.1
Lee index 321 ± 2a 350 ± 2b 314 ± 6a
Retroperitoneal fat pads (% BW) 2.5 ± 0.2a 3.7 ± 0.1b 3.7 ± 0.2b
Perigonadal fat pads (% BW) 1.7 ± 0.2a 2.7 ± 0.1b 2.1 ± 0.1a
Stomach weight/BW ratio × 100 0.4 ± 0.02a 0.3 ± 0.01a 0.5 ± 0.04b
Data are means ± SEM (n = 4–9). Different letters indicate significant difference. One-way ANOVA followed by Tukey posttest (P < 0.05)
Fig. 2 a Plasma glucose and b insulin concentrations, and c
insulin sensitivity, measured by the HOMA-IR in fasted and fed
CTL, CAF Sham, and CAFVag rats. Changes in blood glucose (d)
and total glycemia (e) during the ipGTT. f Insulinemia at 0 and
30 min of the ipGTT. Data are means ± SEM (n = 6–10). *CAF
Sham and CAF Vag are different from CTL. #CAF Sham is
different from the CTL group. Different letters over the bars
indicate significant differences. One-way ANOVA followed by
the Tukey posttest, P < 0.05
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plasma levels were observed in the fed and fasted
state, between all experimental groups (data not
shown).
Islet insulin secretion in response to glucose
and potentiating agents
Figure 3 shows insulin secretion in islets isolated from
CAF rats submitted, or not, to subdiaphragmatic vagal
denervation. The release of insulin at a stimulatory
glucose concentration (11.1 mM) did not differ between
CAF Sham and CTL islets. However, CAF Sham islets
secreted more insulin when stimulated by Cch, a cho-
linergic agonist (P < 0.0001), as well as in response to
intracellular cyclic adenosine monophosphate (cAMP)
elevation by forskolin, an adenylate cyclase activator, or
IBMX, a phosphodiesterase inhibitor (P < 0.001 and P
< 0.05, respectively; Fig. 3). Conversely, isolated islets
from CAF Vag rats secreted less insulin in response to
glucose than islets from the CAF Sham group (P <
0.05). This effect was accompanied by a reduction in
the activation of the cholinergic pathway, since the
insulin release in response to Cch by CAF Vag islets
was approximately 71 and 56 % lower than in the CAF
Sham and CTL groups, respectively. In addition, CAF
Vag islets presented reduced insulin secretion in re-
sponse to forskolin, when compared with CAF Sham
islets (P < 0.0001). When islets were stimulated by
IBMX, a partial reduction in insulin secretion was
observed, since insulin release by CAF Vag islets was
similar to that of CAF Sham and CTL islets (Fig. 3).
Discussion
In this study, we confirm previous observations that the
CAF-style diet effectively induces metabolic damages
that resemble a human Bbad style^ diet, since rats that
consumed the CAF diet were obese, hyperphagic, hy-
perglycemic, hypertriglyceridemic, and insulin resistant.
Fo r t he f i r s t t ime , we demons t r a t ed tha t
subdiaphragmatic vagotomy, after installation of obesi-
ty, is a good strategy for reducing adiposity and amelio-
rating glucose homeostasis in the CAF diet.
Although the pathophysiology of obesity is complex
and not completely understood, several investigations
using obese rodents or humans have demonstrated that
the vagus nerve may contribute to obesity development
and maintenance [3, 4, 17, 19, 30, 31]. An increased
PNS action, associated with reduced SNS activity, is
implicated in fat deposition in hypothalamic, genetic,
and high-fat diet-induced obesity [27, 29, 31]. Accord-
ingly, truncal vagotomy has been shown to be effective
in promoting weight loss [3, 4, 17, 19, 31]. Here, we
demonstrate that vagotomized CAF rats presented de-
creased BW, Lee index and perigonadal fat stores, in
association with only a partial reduction in food con-
sumption, since 12-h food intake in CAF Vag rats was
similar to that of CAF Sham and CTL rats.
The involvement of the PNS in adiposity regulation
also comprises afferent vagus fibers, since Sprague-
Dawley rats presented decreased visceral fat deposition
after 11 months of truncal vagal de-afferentation [31].
Afferent vagal fibers are also involved in the transmis-
sion of satiety signals from the gut to the CNS [25].
Studies indicate that these vagal afferents are altered in
obesity, which contributes to hyperphagia [10, 12]. Con-
sistent with these findings, truncal vagotomy has been
shown to reduce food consumption in rodents [19, 26]
and humans [17]. Conversely, high-fat diet rats did not
demonstrate any alteration in food intake after vagoto-
my or vagal de-afferentiation [31], similarly to our ob-
servations for food consumption in CAF Vag rats.
In agreement with previous observations [2, 28, 34],
we found that the CAF-style diet induced a disruption in
glucose homeostasis. The vagus nerve is also involved
in body glucose control by regulation of insulin action
[14, 18] and pancreatic islet insulin secretion [15].
Fig. 3 Insulin secretion in response to glucose without or with
potentiating agents in islets isolated from CTL, CAF Sham, and
CAF Vag rats. Groups of four islets were incubated for 1 h in the
presence of 11.1 mM glucose alone or with 100 μM Cch, 10 μM
forskolin, or 1 mM IBMX. Data are means ± SEM obtained from
10 to 16 groups of islets in two independent experiments.Different
letters over the bars indicate significant differences. One-way
ANOVA followed by the Tukey posttest, P < 0.05
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Vagotomy has been shown to restore glucose tolerance
in hypothalamic obesity [3, 19]; however, benefits of
vagotomy on body glucose control under high-caloric
regimens have not been reported to date [31]. The
mechanism of action by which PNS contributes to in-
sulin action in peripheral tissues is not completely
known. Studies indicate that hepatic PNS action in the
postprandial state regulates glucose output in the liver
and also produces a factor (denominated hepatic insulin-
sensitizing substance) that enhances insulin peripheral
actions, especially in skeletal muscle [14, 21]. As such,
an impaired PNS action may contribute to glucose in-
tolerance and progression to T2D; it is possible that the
vagus nerve hypertonia in obesity downregulates the
hepatic actions of the PNS, since higher acetylcholines-
terase activity was reported in the liver of obese rodents
[20, 24]. The above observations may suggest that the
partial amelioration of glucose tolerance in CAF Vag
rats may be due to the lack of action of PNS in insulin
target tissues. Therefore, the better fed glycemia,
tryglyceridemia, and insulinemia in the CAF Vag group
may be associated with the lack of cholinergic action
upon endocrine pancreas.
Several lines of investigation demonstrated that, in
hypothalamic and genetic obesity, enhancements in the
PNS act ivi ty in the pancreas contr ibute to
hyperinsulinemia [19, 26], which may increase adipos-
ity. Hyperinsulinemia can also time-dependently down-
regulate the insulin pathway in peripheral tissues [35].
Therefore, these observations indicate that the effects of
PNS hyperactivity on endocrine pancreatic function
may contribute to obesity onset and maintenance.
Our experiments in isolated pancreatic islets demon-
strated that despite presenting hyperinsulinemia, the
CAF Sham group did not alter insulin secretion in
response to glucose. In fact, although hyperinsulinemia
was often been observed in CAF rodents [2, 34], con-
flicting data regarding insulin secretion have been re-
ported, showing reductions in hormone release by fe-
male CAF islets after 4 months of diet ingestion [34],
and increases in insulin secretion in islets frommale rats
that consumed a CAF diet per 10 months [2]. In addi-
tion, we herein observed that CAF Sham islets
hypersecreted insulin in response to the activation of
cholinergic and cAMP pathways, indicating an in-
creased effect of the PNS on the endocrine pancreas,
resulting in increased insulin release to compensate the
lower hormone peripheral action. Increased cAMP-
induced insulin secretion in CAF Sham islets may also
be associated with the activity of the PNS, since cholin-
ergic activity in T2D has also been linked to the cAMP
pathway activation [11], although acetylcholine acts
mainly in the pancreatic β-cells through activation of
the muscarinic type 3/phospholipase C (PLC) pathway,
enhancing intracellular Ca2+ concentrations and PKC
activation [7, 15].
Subdiaphragmatic vagotomy in CAF rats decreased
insulin secretion in response to glucose and normalized
it in response to cAMP. Furthermore, the PLC pathway
also participates in glucose-induced insulin secretion
[33]. Therefore, in CAF Vag rats, the lack of PNS action
on the endocrine pancreas, as confirmed by the lower
insulin release in response to the Cch in this group, may
gradually normalize insulinemia, which restores insulin
peripheral sensitivity. The normalization of blood TG
levels in CAF Vag rats may also be due to the lack of
hepatic PNS action, since vagal action in the liver is
involved in modulation of the insulin-induced hepatic
lipogenesis [22].
In summary, the CAF-style diet in rats efficiently
induced obesity and metabolic disturbances, character-
izing a prediabetic condition. For the first time, we
demonstrated that truncal vagotomy in CAF rats, an
experimental model that closely resembles the human
Bobesogenic^ diet, decreases adiposity and restores in-
sulin sensitivity. These effects were due to the lack of
cholinergic action on the endocrine pancreas, which
normalizes insulinemia and may gradually decrease fat
storage and restore the action of insulin.
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